Norway· NO-ID_678CF181-B69B-4461-84BB-CB2484337BB0

Glyserol SA

A other ophthalmologicals product, registered in Norway by Sykehusapotekene HF.

ATC S01X

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGlyserol SAATCS01XREGISTER NO.NO-ID_678CF181-B69B-4…PACKS LISTED3CHECKEDSeptember 25, 2026

The record

At a glance

FEST (Norway)
Manufacturer
Sykehusapotekene HF
Country
Norway (NO)
ATC code
S01X
ATC class
OTHER OPHTHALMOLOGICALS
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

  • no_merkevare_id
    ID_678CF181-B69B-4461-84BB-CB2484337BB0
  • no_varenummer
    206499
    10
  • gtin
    7072279001067

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f1aa9a1f-0379-49f5-be8f-13de2db4a1d0
GET /v1/drugs/f1aa9a1f-0379-49f5-be8f-13de2db4a1d0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Øre-/øyedråper, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Andre øyemidler",
  "merkevare_id": "ID_678CF181-B69B-4461-84BB-CB2484337BB0",
  "name_form_strength": "Glyserol SA øre/øyedr,oppl",
  "prescription_group": "C"
}

See everything about Glyserol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.